Mengjie Guo

1.5k total citations · 1 hit paper
36 papers, 982 citations indexed

About

Mengjie Guo is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mengjie Guo has authored 36 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Hematology. Recurrent topics in Mengjie Guo's work include Ubiquitin and proteasome pathways (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Cancer-related Molecular Pathways (4 papers). Mengjie Guo is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Cancer-related Molecular Pathways (4 papers). Mengjie Guo collaborates with scholars based in China, United States and Poland. Mengjie Guo's co-authors include Ye Yang, Chunyan Gu, Jinjun Qian, Xiaozhu Tang, Hongyan Ren, Rongfang Wei, Mei Li, Bin Xu, Yanyan Zhou and Qiao Li and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Oncogene.

In The Last Decade

Mengjie Guo

36 papers receiving 977 citations

Hit Papers

Review on circular RNAs a... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengjie Guo China 19 655 340 153 70 67 36 982
Tsung‐Ho Ying Taiwan 15 308 0.5× 131 0.4× 77 0.5× 37 0.5× 27 0.4× 45 646
Xiaoxue Wang China 14 423 0.6× 180 0.5× 48 0.3× 33 0.5× 5 0.1× 51 720
Ryoji Eguchi Japan 15 250 0.4× 85 0.3× 91 0.6× 105 1.5× 19 0.3× 35 570
Misun Park South Korea 19 427 0.7× 140 0.4× 112 0.7× 53 0.8× 45 0.7× 42 932
Si Wang China 18 296 0.5× 71 0.2× 135 0.9× 51 0.7× 15 0.2× 70 815
Stan Gaj Netherlands 14 497 0.8× 210 0.6× 47 0.3× 14 0.2× 14 0.2× 17 855

Countries citing papers authored by Mengjie Guo

Since Specialization
Citations

This map shows the geographic impact of Mengjie Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjie Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjie Guo more than expected).

Fields of papers citing papers by Mengjie Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengjie Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjie Guo. The network helps show where Mengjie Guo may publish in the future.

Co-authorship network of co-authors of Mengjie Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Mengjie Guo. A scholar is included among the top collaborators of Mengjie Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengjie Guo. Mengjie Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ling, Jie Min, Jinjun Qian, et al.. (2025). SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27. Acta Pharmaceutica Sinica B. 15(4). 1991–2007. 1 indexed citations
2.
Yu, Xichao, Mengjie Guo, Xiaozhu Tang, et al.. (2025). Extracellular vesicle-mediated delivery of circp53 suppresses the progression of multiple cancers by activating the CypD/TRAP/HSP90 pathway. Experimental & Molecular Medicine. 57(8). 1711–1726. 2 indexed citations
3.
Deng, Zhendong, Shan‐Liang Sun, Nian Zhou, et al.. (2024). PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway. Advanced Science. 12(5). e2407681–e2407681. 3 indexed citations
4.
Guo, Mengjie, et al.. (2024). The relationship between influenza vaccine hesitancy and vaccine literacy among youth and adults in China. Frontiers in Immunology. 15. 1444393–1444393. 8 indexed citations
5.
Hua, Zhen, Rongfang Wei, Mengjie Guo, et al.. (2022). YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis. Oncogene. 41(10). 1482–1491. 31 indexed citations
6.
Qian, Jinjun, Wei Wu, Yanxin Zhang, et al.. (2021). Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma. Cell Death and Disease. 12(2). 206–206. 18 indexed citations
7.
Gu, Chunyan, Wang Wang, Xiaozhu Tang, et al.. (2021). CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma. Molecular Cancer. 20(1). 84–84. 50 indexed citations
8.
Tang, Xiaozhu, Mengjie Guo, Zhendong Deng, et al.. (2021). BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. Signal Transduction and Targeted Therapy. 6(1). 361–361. 39 indexed citations
9.
Tang, Xiaozhu, Hongyan Ren, Mengjie Guo, et al.. (2021). Review on circular RNAs and new insights into their roles in cancer. Computational and Structural Biotechnology Journal. 19. 910–928. 253 indexed citations breakdown →
10.
Guo, Mengjie, Zhen Zhu, Yanyan Zhou, et al.. (2021). Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma. Frontiers in Cell and Developmental Biology. 9. 675939–675939. 5 indexed citations
11.
Zhou, Hui, Meng Lei, Wang Wang, et al.. (2020). <i>In vitro</i> and <i>in vivo</i> efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma. Aging. 12(22). 22949–22974. 4 indexed citations
12.
Shi, Xu-Qin, Zhenhua Zhu, Shi‐Jun Yue, et al.. (2020). Integration of organ metabolomics and proteomics in exploring the blood enriching mechanism of Danggui Buxue Decoction in hemorrhagic anemia rats. Journal of Ethnopharmacology. 261. 113000–113000. 18 indexed citations
13.
Guo, Mengjie, et al.. (2020). Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway. BMC Complementary Medicine and Therapies. 20(1). 179–179. 19 indexed citations
14.
Lu, Ting, Yan Zhu, Mengjie Guo, et al.. (2020). HUANGKUISIWUFANG inhibits pyruvate dehydrogenase to improve glomerular injury in anti-Thy1 nephritis model. Journal of Ethnopharmacology. 253. 112682–112682. 5 indexed citations
15.
Guo, Mengjie, Chong Wang, Cheng Zhen, et al.. (2019). Genome-wide characterization of aspartic protease (AP) gene family in Populus trichocarpa and identification of the potential PtAPs involved in wood formation. BMC Plant Biology. 19(1). 276–276. 33 indexed citations
16.
Lu, Sizhao, Jinjun Qian, Mengjie Guo, Chunyan Gu, & Ye Yang. (2019). Insights into a Crucial Role of TRIP13 in Human Cancer. Computational and Structural Biotechnology Journal. 17. 854–861. 51 indexed citations
17.
Guo, Mengjie, Dongdong Sun, Zhimin Fan, et al.. (2019). Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma. Frontiers in Oncology. 9. 722–722. 15 indexed citations
18.
Guo, Mengjie, Yan Lyu, Tingting Xu, et al.. (2017). Particle size distribution and respiratory deposition estimates of airborne perfluoroalkyl acids during the haze period in the megacity of Shanghai. Environmental Pollution. 234. 9–19. 44 indexed citations
20.
Guo, Mengjie, et al.. (2011). Involvement of P‐glycoprotein and cytochrome P450 3A in the metabolism of florfenicol of rabbits. Journal of Veterinary Pharmacology and Therapeutics. 35(2). 202–205. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026